Company Data
Avalo Therapeutics Inc.
Ticker
AVTX
Current Price
$4 7.53%
Market Cap
$43.3M
Price Target
Refer to Report
Volume
57.2K
52wk Range
$3.39 - $16
Overview
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.